148 related articles for article (PubMed ID: 35785767)
1. PKCι Is a Promising Prognosis Biomarker and Therapeutic Target for Pancreatic Cancer.
Abdelatty A; Fang D; Wei G; Wu F; Zhang C; Xu H; Yao C; Wang Y; Xia H
Pathobiology; 2022; 89(6):370-381. PubMed ID: 35785767
[TBL] [Abstract][Full Text] [Related]
2. Phosphoglycerate Mutase 1 (PGAM1) Promotes Pancreatic Ductal Adenocarcinoma (PDAC) Metastasis by Acting as a Novel Downstream Target of the PI3K/Akt/mTOR Pathway.
Liu X; Tan X; Liu P; Wu Y; Qian S; Zhang X
Oncol Res; 2018 Aug; 26(7):1123-1131. PubMed ID: 29386088
[TBL] [Abstract][Full Text] [Related]
3. GOLPH2, a gene downstream of ras signaling, promotes the progression of pancreatic ductal adenocarcinoma.
Duan J; Li X; Huang S; Zeng Y; He Y; Liu H; Lin D; Lu D; Zheng M
Mol Med Rep; 2018 Mar; 17(3):4187-4194. PubMed ID: 29344673
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G
J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517
[TBL] [Abstract][Full Text] [Related]
5. Deregulated expression of miR-107 inhibits metastasis of PDAC through inhibition PI3K/Akt signaling via caveolin-1 and PTEN.
Xiong J; Wang D; Wei A; Lu H; Tan C; Li A; Tang J; Wang Y; He S; Liu X; Hu W
Exp Cell Res; 2017 Dec; 361(2):316-323. PubMed ID: 29111166
[TBL] [Abstract][Full Text] [Related]
6. IQGAP1 promotes pancreatic cancer progression and epithelial-mesenchymal transition (EMT) through Wnt/β-catenin signaling.
Hu W; Wang Z; Zhang S; Lu X; Wu J; Yu K; Ji A; Lu W; Wang Z; Wu J; Jiang C
Sci Rep; 2019 May; 9(1):7539. PubMed ID: 31101875
[TBL] [Abstract][Full Text] [Related]
7. Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis.
Guo X; Zhou Q; Su D; Luo Y; Fu Z; Huang L; Li Z; Jiang D; Kong Y; Li Z; Chen R; Chen C
Mol Cancer; 2020 May; 19(1):83. PubMed ID: 32375768
[TBL] [Abstract][Full Text] [Related]
8. Galectin-4 expression is associated with reduced lymph node metastasis and modulation of Wnt/β-catenin signalling in pancreatic adenocarcinoma.
Maftouh M; Belo AI; Avan A; Funel N; Peters GJ; Giovannetti E; Van Die I
Oncotarget; 2014 Jul; 5(14):5335-49. PubMed ID: 24977327
[TBL] [Abstract][Full Text] [Related]
9. LAMB3 mediates apoptotic, proliferative, invasive, and metastatic behaviors in pancreatic cancer by regulating the PI3K/Akt signaling pathway.
Zhang H; Pan YZ; Cheung M; Cao M; Yu C; Chen L; Zhan L; He ZW; Sun CY
Cell Death Dis; 2019 Mar; 10(3):230. PubMed ID: 30850586
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase Ciota is required for pancreatic cancer cell transformed growth and tumorigenesis.
Scotti ML; Bamlet WR; Smyrk TC; Fields AP; Murray NR
Cancer Res; 2010 Mar; 70(5):2064-74. PubMed ID: 20179210
[TBL] [Abstract][Full Text] [Related]
11. FAM84B, amplified in pancreatic ductal adenocarcinoma, promotes tumorigenesis through the Wnt/β-catenin pathway.
Zhang X; Xu J; Yan R; Zhang Y; Hu Z; Fu H; You Q; Cai Q; Yang D
Aging (Albany NY); 2020 Apr; 12(8):6808-6822. PubMed ID: 32291380
[TBL] [Abstract][Full Text] [Related]
12. PRMT1 promotes pancreatic cancer growth and predicts poor prognosis.
Song C; Chen T; He L; Ma N; Li JA; Rong YF; Fang Y; Liu M; Xie D; Lou W
Cell Oncol (Dordr); 2020 Feb; 43(1):51-62. PubMed ID: 31520395
[TBL] [Abstract][Full Text] [Related]
13. HIF-2α regulates non-canonical glutamine metabolism via activation of PI3K/mTORC2 pathway in human pancreatic ductal adenocarcinoma.
Li W; Chen C; Zhao X; Ye H; Zhao Y; Fu Z; Pan W; Zheng S; Wei L; Nong T; Li Z; Chen R
J Cell Mol Med; 2017 Nov; 21(11):2896-2908. PubMed ID: 28544376
[TBL] [Abstract][Full Text] [Related]
14. Activation of WNT/β-Catenin Signaling Enhances Pancreatic Cancer Development and the Malignant Potential Via Up-regulation of Cyr61.
Sano M; Driscoll DR; DeJesus-Monge WE; Quattrochi B; Appleman VA; Ou J; Zhu LJ; Yoshida N; Yamazaki S; Takayama T; Sugitani M; Nemoto N; Klimstra DS; Lewis BC
Neoplasia; 2016 Dec; 18(12):785-794. PubMed ID: 27889647
[TBL] [Abstract][Full Text] [Related]
15. TBL1XR1 induces cell proliferation and inhibit cell apoptosis by the PI3K/AKT pathway in pancreatic ductal adenocarcinoma.
Gu JF; Fu W; Qian HX; Gu WX; Zong Y; Chen Q; Lu L
World J Gastroenterol; 2020 Jul; 26(25):3586-3602. PubMed ID: 32742128
[TBL] [Abstract][Full Text] [Related]
16. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.
Barceló C; Etchin J; Mansour MR; Sanda T; Ginesta MM; Sanchez-Arévalo Lobo VJ; Real FX; Capellà G; Estanyol JM; Jaumot M; Look AT; Agell N
Gastroenterology; 2014 Oct; 147(4):882-892.e8. PubMed ID: 24998203
[TBL] [Abstract][Full Text] [Related]
17. The differential distributions of ASPM isoforms and their roles in Wnt signaling, cell cycle progression, and pancreatic cancer prognosis.
Hsu CC; Liao WY; Chan TS; Chen WY; Lee CT; Shan YS; Huang PJ; Hou YC; Li CR; Tsai KK
J Pathol; 2019 Dec; 249(4):498-508. PubMed ID: 31465125
[TBL] [Abstract][Full Text] [Related]
18. GLRX3, a novel cancer stem cell-related secretory biomarker of pancreatic ductal adenocarcinoma.
Jo JH; Kim SA; Lee JH; Park YR; Kim C; Park SB; Jung DE; Lee HS; Chung MJ; Song SY
BMC Cancer; 2021 Nov; 21(1):1241. PubMed ID: 34794402
[TBL] [Abstract][Full Text] [Related]
19. The Inhibitory Response to PI3K/AKT Pathway Inhibitors MK-2206 and Buparlisib Is Related to Genetic Differences in Pancreatic Ductal Adenocarcinoma Cell Lines.
Ma Y; Sender S; Sekora A; Kong W; Bauer P; Ameziane N; Al-Ali R; Krake S; Radefeldt M; Weiss FU; Lerch MM; Parveen A; Zechner D; Junghanss C; Murua Escobar H
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457111
[TBL] [Abstract][Full Text] [Related]
20. Coupling G2/M arrest to the Wnt/β-catenin pathway restrains pancreatic adenocarcinoma.
Sarkar S; Mandal C; Sangwan R; Mandal C
Endocr Relat Cancer; 2014 Feb; 21(1):113-25. PubMed ID: 24402132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
